High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma

Medulloblastoma Variants: Age-Dependent Occurrence and Relation to Gorlin Syndrome--A New Clinical Perspective

(2009) M. L. Garre et al.   CLINICAL CANCER RESEARCH

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY

Medulloblastoma: From Molecular Pathology to Therapy

(2008) A. Rossi et al.   CLINICAL CANCER RESEARCH

Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients

(2008) F. Zeppernick et al.   CLINICAL CANCER RESEARCH

Cancer stem cells: implications for the progression and treatment of metastatic disease

(2008) A.K Croker et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Medulloblastoma Stem Cells

(2008) Xing Fan et al.   JOURNAL OF CLINICAL ONCOLOGY

Hyperfractionated Accelerated Radiotherapy in the Milan Strategy for Metastatic Medulloblastoma

(2008) Lorenza Gandola et al.   JOURNAL OF CLINICAL ONCOLOGY

Central Nervous System Tumors

(2008) Roger J. Packer et al.   PEDIATRIC CLINICS OF NORTH AMERICA

Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features

(2008) Marcel Kool et al.   PLoS One

Successful isolation and long-term establishment of a cell line with stem cell-like features from an anaplastic medulloblastoma

(2007) A. Raso et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY